Comparing two types of nerve blocks for pain relief after breast surgery
Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Analgesia After Thoracodorsal Artery Perforator Flap Following Partial Mastectomy
This study is testing two different types of nerve blocks to see which one helps adults feel less pain after breast surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 84 (estimated) |
| Ages | 21 Years to 60 Years |
| Sex | All |
| Sponsor | Zagazig University Government |
| Locations | 1 site (Zagazig) |
| Trial ID | NCT05661279 on ClinicalTrials.gov |
What this trial studies
This study evaluates and compares the effectiveness of ultrasound-guided rhomboid intercostal block versus serratus anterior plane block for providing analgesia after a specific type of breast surgery known as thoracodorsal artery perforator flap. The research focuses on assessing the quality of postoperative pain relief, the time taken to perform each block, and monitoring postoperative hemodynamics along with potential adverse effects such as nausea and hypotension. Adult patients aged 21 to 60 undergoing this surgery will be included in the trial, which aims to improve pain management strategies in this surgical context.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 21 to 60 who are undergoing a specific type of breast surgery with general anesthesia.
Not a fit: Patients with certain medical conditions, those on specific medications, or pregnant individuals may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management techniques for patients undergoing breast surgery.
How similar studies have performed: Other studies have shown promise in using similar nerve block techniques for postoperative pain management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients aged between 21 to 60 years * Undergoing pedicled thoracodorsal artery perforator flap following breast conserving surgery -General anesthesia * Informed consents * ASA I \& II * Body mass index 25-30 kg/m2. Exclusion Criteria: * patients on anti-platelet, anticoagulant or B blocker drugs * Patients with acute decompensated heart failure, hypertension, heart block, coronary disease, Asthma, bleeding disorders, compromised renal or hepatic function * history of allergy to local anesthesia or opioid analgesia, * pregnancy.
Where this trial is running
Zagazig
- Heba M Fathi — Zagazig, Egypt (Recruiting)
Study contacts
- Principal investigator: Heba M Fathi — faculty of human medicine ,zagazig university
- Study coordinator: Heba M Fathi, M.D
- Email: heba_elgendi@yahoo.com
- Phone: 01000143938
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.